Christopher James Stevens

Chief Operating Officer · 3 filings · Latest: Aug 11, 2026

ROCKET PHARMACEUTICALS, INC.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
RCKT	Christopher James Stevens	Chief Operating Officer	Aug 11, 2026	Sale	$3.50	36,658	$128.3K	505,784	Aug 13 8:15 PM
RCKT	Stevens Christopher James	—	Aug 11, 2026	Proposed Sale	$3.50	36,658	$128.3K	—	Aug 11 7:30 PM